CoreCap Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.2K Buy
230
+149
+184% +$61.1K ﹤0.01% 1108
2026
Q2
$31.6K Sell
81
-51
-39% -$21.6K ﹤0.01% 1613
2026
Q1
$62.5K Sell
132
-206
-61% -$104K ﹤0.01% 1209
2025
Q4
$158K Buy
338
+166
+97% +$77.1K 0.01% 868
2025
Q3
$73.3K Buy
172
+149
+648% +$57.8K ﹤0.01% 1156
2025
Q2
$8.81K Buy
23
+1
+5% +$360 ﹤0.01% 1926
2025
Q1
$7.6K Sell
22
-57
-72% -$18.3K ﹤0.01% 1938
2024
Q4
$23.7K Sell
79
-444
-85% -$155K ﹤0.01% 1477
2024
Q3
$213K Buy
523
+50
+11% +$18.3K 0.01% 667
2024
Q2
$152K Buy
473
+8
+2% +$2.6K 0.02% 413
2024
Q1
$155K Buy
+465
New +$142K 0.01% 695
2022
Q4
$70.5K Buy
+294
New +$65.8K 0.01% 862
2022
Q1
– Sell
-500
Closed -$128K – 1173
2021
Q4
$128K Buy
+500
New +$122K 0.01% 665

Other funds holding HCA

CoreCap Advisors's HCA Position: Q3 2026 in Review

CoreCap Advisors increased its HCA Healthcare (HCA) stake by 184% in Q3 2026, buying an estimated $61.1K and bringing the position to 230 shares worth $98.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

CoreCap Advisors first reported a position in HCA in Q4 2021 and has held it in 13 quarters since. The position peaked at $213K in Q3 2024. 315 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • CoreCap Advisors held 230 shares of HCA Healthcare worth $98.2K as of Q3 2026.
  • CoreCap Advisors bought 149 HCA Healthcare shares in Q3 2026, an estimated $61.1K.
  • HCA Healthcare made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1108 holding.
  • CoreCap Advisors first reported a position in HCA Healthcare in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's HCA Healthcare position peaked at $213K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.